Cargando…

Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection

Whether the associations between serum vitamin D (VitD) and metabolic-associated fatty liver disease (MAFLD) vary with chronic hepatitis B (CHB) infection has not been well established. This study aims to investigate the relationships between serum VitD and metabolism, liver fat content (LFC) and fi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Ling, Ye, Junzhao, Shao, Congxiang, Lin, Yansong, Sun, Yanhong, Feng, Shiting, Wang, Wei, Zhong, Bihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147199/ https://www.ncbi.nlm.nih.gov/pubmed/35631255 http://dx.doi.org/10.3390/nu14102114

Ejemplares similares

Lipid-Lowering Responses to Dyslipidemia Determine the Efficacy on Liver Enzymes in Metabolic Dysfunction-Associated Fatty Liver Disease with Hepatic Injuries: A Prospective Cohort Study
por: Liao, Xianhua, et al.
Publicado: (2022)

Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease
por: Wu, Tingfeng, et al.
Publicado: (2021)

The Ability of Lipoprotein (a) Level to Predict Early Carotid Atherosclerosis Is Impaired in Patients With Advanced Liver Fibrosis Related to Metabolic-Associated Fatty Liver Disease
por: Wu, Tingfeng, et al.
Publicado: (2022)

Distinct Dose-Dependent Association of Free Fatty Acids with Diabetes Development in Nonalcoholic Fatty Liver Disease Patients
por: Li, Fuxi, et al.
Publicado: (2021)

Discrepancies between Nonalcoholic and Metabolic-associated Fatty Liver Disease by Multiple Steatosis Assessment
por: Shao, Congxiang, et al.
Publicado: (2022)

Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study
por: Ye, Junzhao, et al.
Publicado: (2019)

Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity: assessment using magnetic resonance imaging-derived proton density fat fraction
por: Ye, Junzhao, et al.
Publicado: (2019)

Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease
por: Shao, Congxiang, et al.
Publicado: (2023)

Metabolic benefits of changing sedentary lifestyles in nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials
por: Ma, Qianqian, et al.
Publicado: (2022)

Normalization of γ-glutamyl transferase levels is associated with better metabolic control in individuals with nonalcoholic fatty liver disease
por: Ma, Qianqian, et al.
Publicado: (2021)

Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis
por: Li, Fuxi, et al.
Publicado: (2021)

Impact of skeletal muscle mass evaluating methods on severity of metabolic associated fatty liver disease in non-elderly adults
por: Zhou, Ting, et al.
Publicado: (2023)

Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease
por: Shao, Cong xiang, et al.
Publicado: (2021)

Distinct Cause of Death Profiles of Hospitalized Non-alcoholic Fatty Liver Disease: A 10 Years' Cross-Sectional Multicenter Study in China
por: Lin, Yansong, et al.
Publicado: (2021)

The Additive Values of the Classification of Higher Serum Uric Acid Levels as a Diagnostic Criteria for Metabolic-Associated Fatty Liver Disease
por: He, Jie, et al.
Publicado: (2022)

Dynamic monitoring with shear wave elastography predicts outcomes of chronic hepatitis B patients with decompensated cirrhosis
por: Ye, Junzhao, et al.
Publicado: (2021)

Age patterns of nonalcoholic fatty liver disease incidence: heterogeneous associations with metabolic changes
por: Lin, Yansong, et al.
Publicado: (2022)

Prevalence and Significance of Antinuclear Antibodies in Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Luo, Ling, et al.
Publicado: (2022)

Alterations in Circulating Bile Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis
por: Lai, Jiaming, et al.
Publicado: (2023)

Relationship between Nonalcoholic Fatty Liver Disease and Vitamin D Nutritional Status in Extreme Obesity
por: Cordeiro, Adryana, et al.
Publicado: (2017)

Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future
por: Barchetta, Ilaria, et al.
Publicado: (2017)

Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
por: Dongiovanni, P., et al.
Publicado: (2017)

Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease
por: Chang, Eun Jae, et al.
Publicado: (2015)

The Triglyceride-Glucose Index is Associated with Vitamin D Status in Metabolic-Associated Fatty Liver Disease
por: Liu, Zhiping, et al.
Publicado: (2023)

The relationship between vitamin C status, the gut-liver axis, and metabolic syndrome
por: Traber, Maret G., et al.
Publicado: (2018)

Relationship of Vitamin D Deficiency and Fatty Liver in Children as Defined by Multiple Imaging and Histologic Endpoints
por: Rudolph, Bryan, et al.
Publicado: (2021)

Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
por: Wang, Xin, et al.
Publicado: (2011)

The Present Status of Our Knowledge of the Vitamins
por: Smith, Arthur H., et al.
Publicado: (1933)

Suspected Nonalcoholic Fatty Liver Disease Is Not Associated with Vitamin D Status in Adolescents after Adjustment for Obesity
por: Katz, Karin, et al.
Publicado: (2010)

Vitamin C and vitamin D(3) alleviate metabolic-associated fatty liver disease by regulating the gut microbiota and bile acid metabolism via the gut-liver axis
por: Chen, Qingling, et al.
Publicado: (2023)

Low Vitamin D Status Is Associated with Nonalcoholic Fatty Liver Disease Independent of Visceral Obesity in Korean Adults
por: Seo, Ji A., et al.
Publicado: (2013)

Relationship between Serum 25-hydroxy-vitamin D Concentration and Risk of Metabolic Syndrome in Patients with Fatty Liver
por: Lim, Hee-Sook, et al.
Publicado: (2017)

Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease
por: Cimini, Flavia A, et al.
Publicado: (2017)

Abnormal metabolic processes involved in the pathogenesis of non-alcoholic fatty liver disease (Review)
por: Shao, Mingmei, et al.
Publicado: (2020)

Relationship between Chewing Status and Fatty Liver Diagnosed by Liver/Spleen Attenuation Ratio: A Cross-Sectional Study
por: Iwai, Komei, et al.
Publicado: (2022)

Survival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantation
por: Hwang, Jessica P, et al.
Publicado: (2009)

Hepatic Innervations and Nonalcoholic Fatty Liver Disease
por: Adori, Monika, et al.
Publicado: (2023)

The Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver Disease
por: Li, Jiawei, et al.
Publicado: (2016)

Gender Differences in Vitamin D Status in China
por: Yan, Xiaoning, et al.
Publicado: (2019)

Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy
por: Zheng, Youwei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pd47vgee4j1jm7oabudovrt532